ClinConnect ClinConnect Logo
Search / Trial NCT06344559

Brain Criticality, Oculomotor Control, and Cognitive Effort

Launched by RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY · Mar 27, 2024

Trial Information

Current as of August 20, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how the brain works when healthy young adults perform challenging tasks. Researchers will use special tools like electroencephalography (which measures brain waves) and MRI (a type of brain scan) to observe how the brain adapts and responds to these tasks, especially when stimulated by a technique called transcranial magnetic stimulation. The goal is to better understand brain flexibility, which is how well the brain can adjust to different situations.

To participate, you need to be between 18 and 45 years old, healthy, and free from any diagnosed mental or physical illnesses. You should also be fluent in English and have at least a high school education. If you decide to join, you can expect to undergo two sessions that include brain stimulation and an MRI scan. It’s important to note that individuals with certain conditions, like a history of brain injury or ongoing mental health issues, are not eligible. This study is currently recruiting participants, and your involvement could contribute to important insights about brain function!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Provision of signed and dated informed consent form
  • 2. Stated willingness to comply with all study and availability for the duration of the study
  • 3. Males and females; Ages 18-45
  • 4. Healthy, neurologically normal with no diagnosed mental or physical illness
  • 5. Willingness to adhere to the MRI and two session stimulation protocol
  • 6. Fluent in English
  • 7. Normal or corrected to normal vision
  • 8. At least twelve years of education (high school equivalent)
  • Exclusion Criteria:
  • 1. Ongoing drug or alcohol abuse
  • 2. Diagnosed psychiatric or mental illness
  • 3. Currently taking psychoactive medication
  • 4. Prior brain injury
  • 5. Metal in body
  • 6. History of seizures or diagnosis of epilepsy
  • 7. Claustrophobia
  • 8. Pregnant or possibly pregnant
  • 9. Younger than 18 or older than 45
  • 10. Use of medications which potentially lower the usage threshold

About Rutgers, The State University Of New Jersey

Rutgers, The State University of New Jersey, is a prestigious public research university renowned for its commitment to advancing medical science and public health. As a leading clinical trial sponsor, Rutgers leverages its extensive academic resources, cutting-edge facilities, and a diverse team of experts to conduct innovative research that addresses critical health challenges. The university fosters collaboration across disciplines, engaging in partnerships with healthcare institutions and industry leaders to enhance the development of novel therapies and improve patient outcomes. With a strong emphasis on ethical standards and regulatory compliance, Rutgers is dedicated to advancing clinical knowledge while prioritizing participant safety and well-being in all of its research endeavors.

Locations

Piscataway, New Jersey, United States

Patients applied

0 patients applied

Trial Officials

John A Westbrook, PhD

Principal Investigator

Rutgers University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported